Amedisys (AMED) News Today

SG Americas Securities LLC lifted its stake in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 413.4% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 196,713 shares of the health services provider's stock after p

Bardin Hill Management Partners LP lifted its position in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 21.5% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 120,471 shares of the health servi

Squarepoint Ops LLC lifted its position in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 72.8% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 64,947 shares of the health services provider's stock after purc

Murchinson Ltd. boosted its holdings in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 69.2% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 123,979 shares of the health services provider's stock after acq

Mackenzie Financial Corp decreased its stake in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 1.6% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 745,502 shares of the health services prov

Marshall Wace LLP lessened its position in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 8.0% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 268,122 shares of the health services provider's stock after selling 23,3

Canada Pension Plan Investment Board boosted its stake in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 61.0% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 79,200 shares of the

Skandinaviska Enskilda Banken AB publ increased its holdings in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 43.7% in the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 26,286 shares of the health services provider's stock after purchasing a

Gabelli Funds LLC decreased its stake in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 3.2% during the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 216,337 shares of the health services provider's stock after sellin

Highbridge Capital Management LLC raised its position in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 34.7% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 323,200 shares of the health services pr

Alpine Associates Management Inc. boosted its stake in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 0.9% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,280,897 shares of the health se

National Bank of Canada FI cut its stake in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 65.9% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 25,379 shares of the health services provider's stock a

Great Lakes Advisors LLC cut its holdings in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 5.7% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 129,496 shares of the health ser

Shares of Amedisys, Inc. (NASDAQ:AMED - Get Free Report) have been given a consensus rating of "Hold" by the five ratings firms that are covering the firm, MarketBeat Ratings reports. Four analysts have rated the stock with a hold rating and one has given a buy rating to the company. The average

Privium Fund Management UK Ltd purchased a new stake in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 13,984 shares of the h

GAM Holding AG purchased a new position in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 3,000 shares of the health services provider's stoc

Calamos Advisors LLC grew its position in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 11.6% in the second quarter, according to its most recent filing with the SEC. The fund owned 397,347 shares of the health services provider's stock after acquiring an additional 41,220 shares during the period.

Amedisys, Inc. (NASDAQ:AMED - Get Free Report) was the target of a significant decline in short interest in the month of July. As of July 31st, there was short interest totalling 1,620,000 shares, a decline of 18.2% from the July 15th total of 1,980,000 shares. Approximately 5.1% of the shares of the company are sold short. Based on an average daily volume of 401,100 shares, the short-interest ratio is presently 4.0 days.

SG Americas Securities LLC grew its stake in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 41.6% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 38,315 shares of the health

Cetera Advisors LLC acquired a new stake in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 16,881 shares of the health servic

California State Teachers Retirement System lifted its position in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 65.8% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 54,592 shares of the heal

Russell Investments Group Ltd. lessened its holdings in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 92.4% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,557 shares of the health services provider's stock after sellin

Janus Henderson Group PLC reduced its position in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 22.7% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 285,768 shares of the health services provider's stock after

Vanguard Group Inc. trimmed its stake in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 3.7% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,100,778 shares of the health services provider's stoc

Healthcare of Ontario Pension Plan Trust Fund cut its stake in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 94.8% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,204 shares of the health services provider's stock

Amedisys (NASDAQ:AMED) Reaches New 1-Year High at $98.95

Amedisys, Inc. (NASDAQ:AMED - Free Report) - Equities research analysts at William Blair boosted their Q3 2024 EPS estimates for Amedisys in a report released on Thursday, July 25th. William Blair analyst M. Larew now anticipates that the health services provider will earn $1.15 per share for the

Cantor Fitzgerald reiterated a "neutral" rating and issued a $101.00 target price on shares of Amedisys in a report on Thursday.

Edgestream Partners L.P. reduced its stake in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 18.4% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 49,482 shares of the health services provider's stock after selling 11,154

First Eagle Investment Management LLC decreased its position in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 86.0% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 3,534 shares of the health services provider's stock after selling 21

Shares of Amedisys, Inc. (NASDAQ:AMED - Get Free Report) have been assigned a consensus rating of "Hold" from the five brokerages that are currently covering the stock, Marketbeat reports. Four equities research analysts have rated the stock with a hold rating and one has given a buy rating to th

SG Americas Securities LLC decreased its position in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 57.7% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 27,051 shares of the health services provider's stock after selling 36,902 shares during t

Quantbot Technologies LP purchased a new position in Amedisys, Inc. (NASDAQ:AMED - Free Report) in the first quarter, according to its most recent disclosure with the SEC. The institutional investor purchased 8,260 shares of the health services provider's stock, valued at approximately $761,000. O